Budget 2025 Analysis Key Measures and Opportunities for Financial Institutions The SelfStorage Boom How Vermonts Operators Are Cashing In on Housing Tightness and an Aging Population Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday Barings MCI Stalls at 1730 Consolidation Phase 20260515 WhiteHorse WHFCL Stock Consolidating at 2561 Next Move Ahead 20260518 Cohen LDP Holds 2016 Direction Awaited 20260519 New NWAX Flat at 1009 Consolidation Continues 20260515 HarleyDavidson HOG Q1 2026 Earnings Surprise EPS 030 Up Significant Fed Rate Hike Expectations Surge Traders Price in Potential Move as Soon as December US Tariff Policy May Moderate Trade Representative Hints at Lower but Persistent Barriers Alberta to Hold Referendum on Separation from Canada Separatist Campaign Culminates PutinXi Talks Aim to Revive Stalled Power of Siberia 2 Pipeline Amid Iran Conflict Energy Uncertainty Cancer Treatment Costs Surge Into Hundreds of Thousands ACA Could Offer Relief Survivor Suggests SpaceX Files for Stock Market Debut Under Ticker SPCX Potentially Elevating Elon Musk to Trillionaire Status ONL Q1 2026 Earnings EPS Misses Estimates Despite Minor Stock Uptick SPG Q1 2026 Earnings A Close EPS Miss Reflects Steady Operations Amid Cautious Market HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Discretion FICO Q1 2026 Earnings EPS Surges Past Estimates as Stock Gains 314 COYA Q1 2026 Earnings NarrowerthanExpected Loss as Biotech Advances Pipeline SLDB Q1 2026 Earnings WiderthanExpected Loss as Solid Biosciences Advances Gene Therapy Pipeline Arrow Financial Corporation AROW Edges Higher as Bullish Momentum Builds MIND CTI MNDO Bounces 326 Nearing Key Resistance at 10 Enova International ENVA Shows Strength with 23 Gain Testing Key Resistance Levels Northrop Grumman NOC Holds Steady Near Support Amid Modest Decline Flowco Holdings FLOC Slides Slightly Maintains Position Above Critical Support Tulsi Gabbard Resigns as Trumps Intelligence Chief Market and Political Implications EGP Q1 2026 Earnings EPS Beats Estimates by 681 Amid Flat Stock Movement Ligand Pharmaceuticals LGND Gains Momentum Approaching Key Resistance at 2408